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Background: Carbapenemase producing Enterobacteriaceae
(CPE) is on the rise worldwide. They are currently reported from
all the continents in a variety of environmental settings. Differ-
ent carbapenemases have geographical preponderance with the
blaNDM and blaOXA48 like being prevalent in the Indian sub continent.
Although many Indian studies have reported their prevalence in
the hospital settings, systematic studies on their prevalence in the
community are lacking. Chronic Hemo Dialysis (CHD) patients and
renal transplant (RT) patients are a unique group with constant
interaction with both the community and hospital settings. Hence,
the current study was designed to ﬁnd the prevalence of CPE and
their associated resistant genes from Chronic Hemo Dialysis and
renal transplant patients from a tertiary care centre in Chennai,
South India.
Methods & Materials: A total of 315 non-repetitive enterobac-
terial isolates fromCHDandRTpatientswere included in this study.
They were screened for carbapenem resistance and carbapene-
mase production by antibiotic sensitivity testing and Modiﬁed
Hodge Test respectively. The isolates were identiﬁed by conven-
tional biochemical methods. The carbapenem resistant isolates
were screened for the presence of genes encoding carbapenemases,
Extended Spectrum Beta Lactamases, plasmid AMPCs, 16S rRNA
methlylases and PMQR genes by PCR using published methods.
Results: 32/315 (10%) isolates were found to be CPE isolates
of which 23 were K.pneumoniae and 9 isolates were E.coli. 20/32
(62%) isolates were from renal transplant patients and 12/32 (38%)
were from CHD patients. 28/32 (87.5%) isolates harboured blaNDM
gene with 16/28 (57%) isolates also harbouring a blaOXA48lilke gene.
4/32 (12.5%) isolates harboured blaOXA48lilke gene alone. 31/32(97%)
isolates were positive for blaCTXMgp1 gene and 9/32(28%) isolates
harboured blaCMY . 13/32 (40.6%) isolates were positive for the
armA gene and 5/32 (15.6%) were positive for the rmtB gene. 27/32
(84.4%) isolatesharboured thePMQRdeterminant-aac(6′)-IB-crand
26/32(81.3%) isolates harboured qnrB.
Conclusion: The high prevalence of CPE co-expressing other
clinically relevant resistant genes from CHD and renal transplant
patients substantiates the need for routine surveillance of CPE
among chronic haemodialysis and renal transplant patients to
prevent wide-spread dissemination of carbapenemases into the
community.
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Background: Methicillin-resistant Staphylococcus aureus
(MRSA) is one of the most successful human pathogens respon-
sible for causing a wide range of infections ranging from Toxic
shock syndrome to boils and endocarditis. MRSA has demon-
strated extreme ability to resist antibiotics, thus necessitating a
continuous search for new scaffolds active against it. Fosfomycin,
a clinically utilized antibiotic for the treatment of MRSA infections,
is known to act through covalent modiﬁcation of biological thiols
with its epoxide functionality. 2,3 epoxy-1,4-naphthoquinones
are found to be constituents of numerous natural products. These
compounds are found to be reactive with cellular thiols and
generate reactive oxygen species (ROS), which can act to induce
oxidative stress. Thiols, such as cysteine and glutathione are
important for the maintenance of redox homeostasis in cells and
hence, depletion of thiols could induce cellular stress and trigger
cell death. Thus, such compoundsmight have therapeutic potential
against MRSA infections.
Methods&Materials:We synthesized a library of indole-based
2,3 epoxy-1,4-naphthoquinones, varying the substitution on the
epoxide carbons, and studied their reactivity with thiols, such as
cysteine and glutathione. The synthesis of these compounds was
undertaken in ﬁve steps from commercially available indole-3-
carboxaldehyde.
Results: These compounds showed potent activity against
drug-resistant clinical isolates of S. aureus including VRSA with
MIC ranging from 0.06-0.12 mg/L. A good correlation was found
between thiol-mediated decomposition proﬁles and MIC values of
these compounds. The selectivity index of these compounds was
>200, thus indicating speciﬁcity forbacterial cells andwere found to
be non-haemolytic against human RBCs. These compounds exhib-
ited concentration dependent bactericidal activity with a ∼5 log
killing at 24 h in comparison to drug free control. These compounds
